| P2093 | author name string | Satoshi Yamashita | |
| | Chizu Yokoi | |
| | Kazuhiko Yamada | |
| | Taeko Dohi | |
| | Teruki Hagiwara | |
| | Toru Igari | |
| | Yuki I Kawamura | |
| | Kyoko Nohara | |
| | Daisuke Soma | |
| | Leo Yamada | |
| P2860 | cites work | Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues | Q22253907 |
| | Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer | Q24642830 |
| | The emerging roles of human tissue kallikreins in cancer | Q28290701 |
| | Comprehensive Registry of Esophageal Cancer in Japan, 2010. | Q33840374 |
| | Oesophageal carcinoma | Q34325751 |
| | The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer | Q37228450 |
| | KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma | Q37400530 |
| | Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers | Q38055059 |
| | Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management | Q38831243 |
| | Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer | Q39201211 |
| | Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung | Q39961334 |
| | Esophageal cancer chemotherapy: recent advances. | Q43194164 |
| | DNA hypermethyation and silencing of PITX1 correlated with advanced stage and poor postoperative prognosis of esophageal squamous cell carcinoma. | Q47121817 |
| | Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum | Q47225144 |
| | Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis. | Q51062025 |
| | Alteration of gene expression and DNA methylation in drug-resistant gastric cancer. | Q54223981 |
| | Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay | Q57942337 |
| | Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation | Q84148673 |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| P577 | publication date | 2018-03-26 | |
| P1433 | published in | General thoracic and cardiovascular surgery | Q26842769 |
| P1476 | title | Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma. | |